Covid-19 vaccination acceptance among students of the Higher Institute of Medical Techniques of Lubumbashi, Democratic Republic of Congo
##semicolon##
COVID-19##common.commaListSeparator## Vaccine##common.commaListSeparator## Students##common.commaListSeparator## Acceptance##common.commaListSeparator## Lubumbashiसार
Objective: To assess the acceptance and intention to receive the Covid-19 vaccine and the associated factors if it is offered to students, as they are directly exposed to the disease during the various internships.
Methods: This is a cross-sectional descriptive study, carried out within the Higher Institute of Medical Techniques in Lubumbashi from September 4 to 5, 2020. The sample was non-random for convenience, and included 439 students who gave their consent to participate in the survey. The main result was the students' willingness to accept a future vaccine against covid-19. Stepwise logistic regression was used to identify predictors of willingness to be vaccinated against Covid-19.
Results: Of a total of 439 respondents, 330 (75.2%) were female and 109 (24.8%) were male. The mean age was 26.5 ± 6.5 years. Only 25.3% of students said they would receive the covid-19 vaccine if it was available. After logistic regression, male students (AOR = 2.24 [1.40-3.58]; p = 0.001), those who regularly consult official sites (AOR = 0.24 [0.90-0, 68]; p = 0.004) and students with poor knowledge of Covid-19 (AOR = 1.73 [0.45-0.02]; p = 0.000) were significantly associated with the desire to be vaccinated.
Conclusion: For the COVID-19 vaccination acceptance by the population, the education of future health workers must be considered as a priority, because the attitude of the latter towards vaccines has proved to be a determining factor important to their own use of the vaccine, their intention to recommend the vaccine to their patients.
##submission.citations##
Chinese center for Disease control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-china 2020.chinese CDC weekly 2020 ;2 ;1-10.
Kabamba LN, Kabamba MO, Mukonkole JN, Kabyla BL, Luboya ON. Connaissances, attitudes et pratiques des travailleurs des officines privées sur la covid-19 : cas de la commune de Kintambo à Kinshasa. Revue de l’infirmier congolais.2020 ;4(1) :6-8.
OMS. Nouveau coronavirus(2019-nCov). Genève : OMS ; 2020. Accessible sur : htts://www.who.int/fr/emergencies/diseases/novel-coronavirus-2019.
OMS. Nouveau coronavirus(2019-nCov). Genève : OMS ; 2020. Accessible sur : https://covid19.who.int
OMS. COVID-19 in the WHO African Region. Accessible in: https://who.maps.arcgis.com/apps/opsdashboard/index.html#/0c9b3a8b68d0437a8cf28581e9c063a9.
DRC Ministry of Health. COVID-19 epidemiological status in Democratic Republic of Congo. Accessible sur : https://www.stopcoronavirusrdc.info/
Ministère provincial de la santé. Rapport Covid-19. Division provinciale de la santé : Lubumbashi ; 2020.
Fu C, Wei Z, Pei S, Li S, Sun X, Liu P. Acceptance and preference for COVID-19 vaccination in health-care workers (HCWs). medRxiv. 2020;2962(548):2020.
Paterson P, Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL. Vaccine hesitancy and healthcare providers Vaccine hesitancy and healthcare providers. Vaccine. 2016;(October).
Kumar D, Chandra R, Mathur M, Samdariya S, Kapoor N. Vaccine hesitancy : understanding better to address better. Isr J Health Policy Res. 2016;5(2):1-8.
Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. Published online 2020:1-5.
Abdala AK, Kanteng GAW, Shongo MYP, Manya HM, Lubala TK, Mutombo AM, Momat FK, et al. Stratégies de contrôle de la pandémie de covid-19 : Le pont sur les voets thérapeutiques et vaccinal. Revue de l’infirmier Congolais.2020.
Detoc M, Bruel S, Frappe P, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. medRxiv. Published online 2020:1-14.
Garrett L. COVID-19: the medium is the message. Lancet. 2020;395(January):1-3.
OMS. Nouveau coronavirus(2019-nCov).Genève : OMS ; 2020. Accessible sur : htts://www.who.int/fr/emergencies/diseases/novel-coronavirus-2019.
Pulcini C, Massin S, Launay O, Verger P. Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners : a 2010 survey. Vaccine. 2013;31(37):3943-3949.
Jones M, Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Heal. 2008;57(1):23-32.
Zhi ZLXBXZ. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese J Epidemiol. 2020;41(2):145-151.
Denis M, Vandeweerd V, Verbeke R, Laudisoit A, Wynants L, Vliet D Van Der. COVIPENDIUM:Information Available to Support the Development of Medical Countermeasures and Interventions against COVID-19.; 2020.
Biswas R. Are Men More Vulnerable to Covid-19 as Compared to Women ? Biomed J Sci Tech Res. 2020;27(2).
Massé R et coll : Perception populaires du risque et savoirs experts en contexte de pandémie : le cas du A (H1N1) au Quebec. Anthropol santé Rev int Francoph Anthropol .santé 2011 ;(3).
Pierrefixe S.Vaccins : Pourquoi font-ils peur ? Rubr Gd Angle.2015.
Dubey S, Biswas P, Ghosh R, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(January):779-788.
Rapport d’enquête CAP(Connaissances, attitudes et pratiques) sur le Coronavirus (COVID-19) dans les départements du Mayo-Sava et du Mayo-Tsanaga Région de l’Extrême-Nord Cameroun ;juillet 2020.
Sondage YouGov pour le HuffPost, Juillet 2020 ; France.
Olum R, Chekwech G, Wekha G, Nassozi DR, Bongomin F. Coronavirus Disease-2019: Knowledge, Attitude, and Practices of Health Care Workers at Makerere University Teaching Hospitals, Uganda. Front Public Heal. 2020;8(April):1-9.
